Open AccessNetwork meta-analysis of infliximab biosimilars for the treatment of rheumatoid arthritis
Author(s) -
Conor Hanrahan,
Todd A. Lee
Publication year - 2021
Publication title -
american journal of health-system pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.487
H-Index - 96
eISSN - 1535-2900
pISSN - 1079-2082
DOI - 10.1093/ajhp/zxab042
Subject(s) - infliximab , medicine , biosimilar , rheumatoid arthritis , meta analysis , adverse effect , randomized controlled trial , odds ratio , rheumatology , tumor necrosis factor alpha
This article assesses the relative efficacy and safety of infliximab biosimilars in treatment of patients with rheumatoid arthritis (RA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom